Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Sleeping beauty: awakening urothelium from its slumber.

Balsara ZR, Li X.

Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F732-F743. doi: 10.1152/ajprenal.00337.2016. Epub 2017 Jan 25. Review.

2.

Risk Factors Associated With Recurrent Urinary Tract Infection in Neurogenic Bladders Managed by Clean Intermittent Catheterization.

Chaudhry R, Balsara ZR, Madden-Fuentes RJ, Wiener JS, Routh JC, Seed P, Ross SS.

Urology. 2017 Apr;102:213-218. doi: 10.1016/j.urology.2016.12.049. Epub 2017 Jan 5.

PMID:
28065810
3.

Stage- and subunit-specific functions of polycomb repressive complex 2 in bladder urothelial formation and regeneration.

Guo C, Balsara ZR, Hill WG, Li X.

Development. 2017 Feb 1;144(3):400-408. doi: 10.1242/dev.143958. Epub 2017 Jan 3.

4.

Variation in use of nephron-sparing surgery among children with renal tumors.

Chu DI, Lloyd JC, Balsara ZR, Wiener JS, Ross SS, Routh JC.

J Pediatr Urol. 2014 Aug;10(4):724-9. doi: 10.1016/j.jpurol.2013.12.019. Epub 2014 Jan 22.

5.

Congenital spigelian hernia and ipsilateral cryptorchidism: raising awareness among urologists.

Balsara ZR, Martin AE, Wiener JS, Routh JC, Ross SS.

Urology. 2014 Feb;83(2):457-9. doi: 10.1016/j.urology.2013.09.032. Epub 2013 Nov 26.

PMID:
24286599
6.

Enhanced susceptibility to urinary tract infection in the spinal cord-injured host with neurogenic bladder.

Balsara ZR, Ross SS, Dolber PC, Wiener JS, Tang Y, Seed PC.

Infect Immun. 2013 Aug;81(8):3018-26. doi: 10.1128/IAI.00255-13. Epub 2013 Jun 10.

7.

Experience with glycerin for antegrade continence enema in patients with neurogenic bowel.

Chu DI, Balsara ZR, Routh JC, Ross SS, Wiener JS.

J Urol. 2013 Feb;189(2):690-3. doi: 10.1016/j.juro.2012.08.209. Epub 2012 Oct 8.

8.

Chlamydia trachomatis infection induces cleavage of the mitotic cyclin B1.

Balsara ZR, Misaghi S, Lafave JN, Starnbach MN.

Infect Immun. 2006 Oct;74(10):5602-8.

9.

The p47 GTPases Igtp and Irgb10 map to the Chlamydia trachomatis susceptibility locus Ctrq-3 and mediate cellular resistance in mice.

Bernstein-Hanley I, Coers J, Balsara ZR, Taylor GA, Starnbach MN, Dietrich WF.

Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14092-7. Epub 2006 Sep 7.

10.

Chlamydia trachomatis-derived deubiquitinating enzymes in mammalian cells during infection.

Misaghi S, Balsara ZR, Catic A, Spooner E, Ploegh HL, Starnbach MN.

Mol Microbiol. 2006 Jul;61(1):142-50.

11.

Developmental regulation of Chlamydia trachomatis class I accessible protein-1, a CD8+ T cell antigen.

Balsara ZR, Roan NR, Steele LN, Starnbach MN.

J Infect Dis. 2006 May 15;193(10):1459-63. Epub 2006 Apr 12.

PMID:
16619195
12.

Genetic analysis of susceptibility to Chlamydia trachomatis in mouse.

Bernstein-Hanley I, Balsara ZR, Ulmer W, Coers J, Starnbach MN, Dietrich WF.

Genes Immun. 2006 Mar;7(2):122-9.

PMID:
16395389
13.

Hematopoietic cells are required to initiate a Chlamydia trachomatis-specific CD8+ T cell response.

Steele LN, Balsara ZR, Starnbach MN.

J Immunol. 2004 Nov 15;173(10):6327-37.

Supplemental Content

Loading ...
Support Center